Darleen Sandoval
Concepts (425)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrectomy | 35 | 2022 | 82 | 9.530 |
Why?
| Glucagon-Like Peptide 1 | 33 | 2022 | 100 | 7.910 |
Why?
| Bariatric Surgery | 17 | 2022 | 161 | 4.730 |
Why?
| Glucose | 34 | 2023 | 897 | 4.720 |
Why?
| Obesity | 46 | 2022 | 2514 | 4.280 |
Why?
| Weight Loss | 26 | 2022 | 642 | 3.900 |
Why?
| Blood Glucose | 45 | 2023 | 1821 | 3.760 |
Why?
| Homeostasis | 25 | 2021 | 576 | 3.480 |
Why?
| Glucagon-Secreting Cells | 5 | 2023 | 20 | 3.130 |
Why?
| Gastric Bypass | 10 | 2022 | 92 | 2.970 |
Why?
| Hypoglycemia | 13 | 2022 | 386 | 2.960 |
Why?
| Glucagon-Like Peptide-1 Receptor | 19 | 2020 | 71 | 2.910 |
Why?
| Proglucagon | 9 | 2023 | 9 | 2.710 |
Why?
| Energy Metabolism | 21 | 2021 | 724 | 2.370 |
Why?
| Insulin | 37 | 2023 | 2079 | 2.330 |
Why?
| Hypothalamus | 10 | 2018 | 147 | 2.170 |
Why?
| Diabetes Mellitus, Type 2 | 17 | 2022 | 2096 | 1.980 |
Why?
| Glucagon | 10 | 2021 | 93 | 1.950 |
Why?
| Eating | 21 | 2023 | 347 | 1.940 |
Why?
| Body Weight | 22 | 2021 | 868 | 1.790 |
Why?
| Animals | 108 | 2023 | 31839 | 1.770 |
Why?
| Diabetes Mellitus | 6 | 2021 | 904 | 1.690 |
Why?
| Receptors, Glucagon | 10 | 2019 | 23 | 1.440 |
Why?
| Pancreas | 6 | 2021 | 277 | 1.400 |
Why?
| Diet, High-Fat | 15 | 2021 | 225 | 1.380 |
Why?
| Neurons | 11 | 2023 | 1282 | 1.370 |
Why?
| Rats | 38 | 2022 | 4963 | 1.350 |
Why?
| Central Nervous System | 8 | 2014 | 238 | 1.330 |
Why?
| Solitary Nucleus | 4 | 2023 | 15 | 1.280 |
Why?
| Intestinal Mucosa | 6 | 2019 | 530 | 1.220 |
Why?
| Rats, Long-Evans | 18 | 2020 | 98 | 1.180 |
Why?
| Incretins | 5 | 2017 | 15 | 1.140 |
Why?
| Hyperglycemia | 6 | 2023 | 292 | 1.110 |
Why?
| Leptin | 6 | 2020 | 211 | 1.080 |
Why?
| Mice | 50 | 2023 | 14936 | 1.070 |
Why?
| Glucose Tolerance Test | 15 | 2021 | 343 | 1.000 |
Why?
| Postprandial Period | 7 | 2021 | 87 | 0.990 |
Why?
| Gastrointestinal Hormones | 2 | 2017 | 8 | 0.970 |
Why?
| Food Preferences | 6 | 2017 | 108 | 0.960 |
Why?
| Receptors, Leptin | 4 | 2020 | 24 | 0.960 |
Why?
| Diet, Fat-Restricted | 3 | 2021 | 73 | 0.960 |
Why?
| Mice, Knockout | 23 | 2023 | 2587 | 0.960 |
Why?
| Insulin-Secreting Cells | 6 | 2021 | 317 | 0.940 |
Why?
| Bile Acids and Salts | 4 | 2022 | 172 | 0.930 |
Why?
| Brain | 8 | 2018 | 2372 | 0.810 |
Why?
| Stomach | 6 | 2016 | 101 | 0.810 |
Why?
| Gastrointestinal Tract | 4 | 2019 | 169 | 0.800 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2023 | 162 | 0.770 |
Why?
| Intestines | 3 | 2017 | 326 | 0.760 |
Why?
| Signal Transduction | 13 | 2020 | 4525 | 0.750 |
Why?
| Food | 4 | 2017 | 160 | 0.750 |
Why?
| Male | 65 | 2021 | 55663 | 0.740 |
Why?
| Gastric Inhibitory Polypeptide | 2 | 2019 | 14 | 0.720 |
Why?
| Pancreatic Hormones | 1 | 2020 | 3 | 0.710 |
Why?
| Dipeptidyl Peptidase 4 | 2 | 2019 | 10 | 0.700 |
Why?
| Oleic Acids | 1 | 2020 | 10 | 0.700 |
Why?
| Ethanolamines | 1 | 2020 | 19 | 0.700 |
Why?
| Exercise | 7 | 2006 | 1643 | 0.700 |
Why?
| Endocannabinoids | 1 | 2020 | 37 | 0.680 |
Why?
| Feeding Behavior | 7 | 2020 | 572 | 0.680 |
Why?
| Epinephrine | 9 | 2007 | 167 | 0.670 |
Why?
| Fasting | 5 | 2021 | 242 | 0.670 |
Why?
| Duodenum | 3 | 2022 | 62 | 0.670 |
Why?
| Sex Characteristics | 3 | 2019 | 635 | 0.670 |
Why?
| Lipid Metabolism | 5 | 2017 | 446 | 0.660 |
Why?
| Gene Expression Regulation | 7 | 2020 | 2324 | 0.660 |
Why?
| Appetite Depressants | 3 | 2018 | 18 | 0.650 |
Why?
| Mice, Inbred C57BL | 19 | 2021 | 4719 | 0.650 |
Why?
| Liver | 6 | 2021 | 1634 | 0.640 |
Why?
| Leadership | 1 | 2021 | 295 | 0.610 |
Why?
| Peripheral Nervous System | 1 | 2018 | 17 | 0.610 |
Why?
| Basal Metabolism | 1 | 2018 | 46 | 0.600 |
Why?
| Diabetes Mellitus, Type 1 | 8 | 2019 | 3248 | 0.590 |
Why?
| Metabolism | 1 | 2017 | 35 | 0.590 |
Why?
| Hormones | 6 | 2013 | 133 | 0.590 |
Why?
| Gastric Emptying | 2 | 2016 | 40 | 0.590 |
Why?
| Gastroplasty | 4 | 2022 | 26 | 0.560 |
Why?
| Peptides | 11 | 2022 | 848 | 0.540 |
Why?
| Anorexia | 2 | 2014 | 18 | 0.540 |
Why?
| Humans | 56 | 2022 | 114937 | 0.540 |
Why?
| Prader-Willi Syndrome | 1 | 2016 | 25 | 0.530 |
Why?
| N-Acetylglucosaminyltransferases | 2 | 2022 | 22 | 0.530 |
Why?
| Jejunum | 1 | 2015 | 24 | 0.520 |
Why?
| Running | 1 | 2018 | 207 | 0.510 |
Why?
| Gastric Mucosa | 3 | 2014 | 46 | 0.510 |
Why?
| Disease Models, Animal | 14 | 2021 | 3549 | 0.500 |
Why?
| Intestinal Absorption | 1 | 2015 | 93 | 0.500 |
Why?
| Glucose Clamp Technique | 12 | 2015 | 181 | 0.480 |
Why?
| Apolipoproteins A | 1 | 2014 | 18 | 0.480 |
Why?
| Hyperphagia | 1 | 2014 | 28 | 0.460 |
Why?
| Rhombencephalon | 2 | 2018 | 28 | 0.440 |
Why?
| Venoms | 6 | 2017 | 30 | 0.430 |
Why?
| Glucokinase | 1 | 2012 | 13 | 0.430 |
Why?
| Vitamin D | 1 | 2016 | 341 | 0.420 |
Why?
| Ribosomal Proteins | 1 | 2013 | 70 | 0.420 |
Why?
| Ileum | 1 | 2013 | 92 | 0.420 |
Why?
| Hypoglycemic Agents | 10 | 2019 | 1008 | 0.420 |
Why?
| Adaptation, Physiological | 2 | 2015 | 483 | 0.420 |
Why?
| Triglycerides | 5 | 2021 | 470 | 0.420 |
Why?
| Estradiol | 2 | 2007 | 455 | 0.410 |
Why?
| Malabsorption Syndromes | 2 | 2011 | 15 | 0.410 |
Why?
| Lipids | 6 | 2021 | 582 | 0.410 |
Why?
| Malnutrition | 1 | 2013 | 61 | 0.410 |
Why?
| Emotions | 1 | 2017 | 472 | 0.400 |
Why?
| Norepinephrine | 8 | 2007 | 207 | 0.390 |
Why?
| Insulin Resistance | 5 | 2018 | 1072 | 0.390 |
Why?
| Receptor, Melanocortin, Type 4 | 4 | 2019 | 11 | 0.370 |
Why?
| Liraglutide | 5 | 2018 | 27 | 0.350 |
Why?
| Toll-Like Receptor 5 | 1 | 2010 | 14 | 0.350 |
Why?
| Dietary Fats | 7 | 2014 | 287 | 0.350 |
Why?
| Stress, Physiological | 2 | 2003 | 378 | 0.350 |
Why?
| Dexamethasone | 3 | 2017 | 317 | 0.350 |
Why?
| Fibroblast Growth Factors | 3 | 2022 | 162 | 0.340 |
Why?
| Receptors, Somatotropin | 2 | 2021 | 9 | 0.330 |
Why?
| Bacterial Physiological Phenomena | 1 | 2010 | 57 | 0.330 |
Why?
| Ventromedial Hypothalamic Nucleus | 2 | 2020 | 4 | 0.330 |
Why?
| Neurosecretory Systems | 2 | 2013 | 32 | 0.320 |
Why?
| Nicotine | 1 | 2011 | 266 | 0.320 |
Why?
| Immune System | 1 | 2010 | 173 | 0.320 |
Why?
| Female | 24 | 2021 | 59581 | 0.310 |
Why?
| Enteroendocrine Cells | 2 | 2020 | 5 | 0.300 |
Why?
| Hydrocortisone | 4 | 2005 | 270 | 0.300 |
Why?
| Prosencephalon | 1 | 2007 | 45 | 0.300 |
Why?
| Arcuate Nucleus of Hypothalamus | 2 | 2021 | 13 | 0.290 |
Why?
| Autonomic Nervous System | 3 | 2006 | 70 | 0.290 |
Why?
| Receptors, Glucocorticoid | 2 | 2008 | 131 | 0.290 |
Why?
| Body Composition | 7 | 2017 | 585 | 0.280 |
Why?
| Metabolic Syndrome | 1 | 2010 | 323 | 0.270 |
Why?
| Drug Delivery Systems | 1 | 2009 | 296 | 0.270 |
Why?
| Hyperinsulinism | 6 | 2013 | 103 | 0.270 |
Why?
| Rats, Sprague-Dawley | 7 | 2008 | 2211 | 0.270 |
Why?
| Progesterone | 1 | 2007 | 232 | 0.260 |
Why?
| Autonomic Nervous System Diseases | 1 | 2006 | 27 | 0.260 |
Why?
| Hypoxia | 2 | 2003 | 960 | 0.260 |
Why?
| Gene Expression | 4 | 2020 | 1422 | 0.260 |
Why?
| Muscle, Skeletal | 6 | 2021 | 1472 | 0.260 |
Why?
| Adipose Tissue | 4 | 2021 | 539 | 0.260 |
Why?
| Adiposity | 4 | 2019 | 457 | 0.240 |
Why?
| Lactic Acid | 2 | 2003 | 275 | 0.230 |
Why?
| Smoking | 1 | 2011 | 1391 | 0.230 |
Why?
| Dehydroepiandrosterone Sulfate | 1 | 2004 | 45 | 0.230 |
Why?
| Adipose Tissue, White | 3 | 2020 | 27 | 0.220 |
Why?
| Ethanol | 1 | 2007 | 548 | 0.220 |
Why?
| Ghrelin | 2 | 2013 | 33 | 0.210 |
Why?
| Postoperative Complications | 3 | 2019 | 2133 | 0.210 |
Why?
| Streptozocin | 1 | 2023 | 17 | 0.210 |
Why?
| Contraceptives, Oral | 1 | 2003 | 25 | 0.210 |
Why?
| Gastrointestinal Microbiome | 2 | 2019 | 502 | 0.210 |
Why?
| Mice, Transgenic | 4 | 2020 | 1953 | 0.210 |
Why?
| Circadian Rhythm | 4 | 2019 | 355 | 0.200 |
Why?
| Estrogen Replacement Therapy | 1 | 2003 | 116 | 0.200 |
Why?
| Endocrine Glands | 1 | 2002 | 16 | 0.200 |
Why?
| Lactobacillus | 1 | 2022 | 24 | 0.200 |
Why?
| Adipocytes | 3 | 2019 | 188 | 0.190 |
Why?
| Body Mass Index | 2 | 2021 | 1961 | 0.190 |
Why?
| Pancreatitis | 3 | 1997 | 107 | 0.190 |
Why?
| Corticosterone | 3 | 2007 | 211 | 0.190 |
Why?
| Glucagon-Like Peptide-2 Receptor | 2 | 2020 | 3 | 0.190 |
Why?
| Nucleus Accumbens | 1 | 2022 | 124 | 0.190 |
Why?
| Energy Intake | 5 | 2018 | 420 | 0.190 |
Why?
| Glutamic Acid | 1 | 2022 | 211 | 0.190 |
Why?
| Ovariectomy | 1 | 2021 | 116 | 0.180 |
Why?
| Amino Acids, Branched-Chain | 1 | 2020 | 31 | 0.180 |
Why?
| Gene Expression Profiling | 2 | 2019 | 1523 | 0.180 |
Why?
| Scavenger Receptors, Class B | 1 | 2020 | 9 | 0.180 |
Why?
| Receptors, Calcitonin | 1 | 2020 | 2 | 0.180 |
Why?
| Glucose Intolerance | 4 | 2014 | 138 | 0.170 |
Why?
| PPAR alpha | 1 | 2020 | 52 | 0.170 |
Why?
| Anti-Inflammatory Agents | 1 | 2003 | 451 | 0.170 |
Why?
| Bromocriptine | 1 | 2019 | 26 | 0.170 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 225 | 0.170 |
Why?
| Dopamine Agonists | 1 | 2019 | 31 | 0.170 |
Why?
| Mice, Obese | 2 | 2017 | 53 | 0.170 |
Why?
| Linagliptin | 1 | 2019 | 4 | 0.170 |
Why?
| Integrases | 1 | 2020 | 116 | 0.170 |
Why?
| Pancreas, Exocrine | 1 | 2019 | 8 | 0.170 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 43 | 0.160 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 71 | 0.160 |
Why?
| Gene Knockout Techniques | 1 | 2019 | 99 | 0.160 |
Why?
| Dyslipidemias | 1 | 2020 | 154 | 0.160 |
Why?
| Paraventricular Hypothalamic Nucleus | 2 | 2016 | 23 | 0.160 |
Why?
| Administration, Oral | 2 | 2020 | 731 | 0.160 |
Why?
| Bone Resorption | 1 | 2019 | 73 | 0.160 |
Why?
| Cardiovascular System | 3 | 2006 | 126 | 0.160 |
Why?
| Nuclear Proteins | 2 | 2022 | 593 | 0.150 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2020 | 192 | 0.150 |
Why?
| Bone Marrow Cells | 1 | 2019 | 267 | 0.150 |
Why?
| Stem Cells | 1 | 2022 | 546 | 0.150 |
Why?
| Sensation | 1 | 2017 | 44 | 0.140 |
Why?
| Inflammation | 4 | 2019 | 2485 | 0.140 |
Why?
| Injections, Intraperitoneal | 1 | 2017 | 100 | 0.140 |
Why?
| Gene Targeting | 1 | 2017 | 75 | 0.140 |
Why?
| Up-Regulation | 1 | 2020 | 812 | 0.140 |
Why?
| Immunohistochemistry | 3 | 2016 | 1635 | 0.140 |
Why?
| Physical Conditioning, Animal | 2 | 2016 | 195 | 0.140 |
Why?
| Diterpenes | 1 | 1996 | 31 | 0.140 |
Why?
| Dietary Carbohydrates | 2 | 2014 | 137 | 0.140 |
Why?
| Platelet Activating Factor | 1 | 1996 | 87 | 0.140 |
Why?
| Organ Specificity | 1 | 2017 | 270 | 0.130 |
Why?
| Neural Pathways | 1 | 2018 | 258 | 0.130 |
Why?
| Cholesterol | 1 | 2018 | 368 | 0.130 |
Why?
| Receptors, Calcitriol | 1 | 2016 | 53 | 0.130 |
Why?
| Diet | 2 | 2021 | 1077 | 0.130 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 929 | 0.130 |
Why?
| Sex Factors | 1 | 2021 | 1721 | 0.130 |
Why?
| Electrophysiology | 1 | 2016 | 201 | 0.130 |
Why?
| Microbiota | 1 | 2022 | 649 | 0.120 |
Why?
| Cell Differentiation | 1 | 2022 | 1699 | 0.120 |
Why?
| Heterozygote | 2 | 2012 | 251 | 0.120 |
Why?
| Lighting | 1 | 2015 | 25 | 0.120 |
Why?
| MicroRNAs | 1 | 2021 | 601 | 0.120 |
Why?
| Injections, Intraventricular | 2 | 2004 | 71 | 0.120 |
Why?
| Receptors, Ghrelin | 1 | 2013 | 7 | 0.110 |
Why?
| Diet, Carbohydrate-Restricted | 1 | 2013 | 28 | 0.110 |
Why?
| Oxygen | 1 | 2018 | 853 | 0.110 |
Why?
| Dietary Proteins | 1 | 2014 | 123 | 0.110 |
Why?
| Satiation | 1 | 2013 | 22 | 0.110 |
Why?
| Glucocorticoids | 1 | 2017 | 534 | 0.110 |
Why?
| Aminoimidazole Carboxamide | 1 | 2012 | 10 | 0.110 |
Why?
| Sleep Deprivation | 1 | 2015 | 166 | 0.110 |
Why?
| Diabetes Complications | 1 | 2014 | 211 | 0.110 |
Why?
| Ribonucleotides | 1 | 2012 | 24 | 0.110 |
Why?
| Satiety Response | 1 | 2012 | 8 | 0.100 |
Why?
| Sympathetic Nervous System | 2 | 2004 | 171 | 0.100 |
Why?
| Exercise Therapy | 1 | 2016 | 351 | 0.100 |
Why?
| Weight Gain | 2 | 2016 | 451 | 0.100 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 193 | 0.100 |
Why?
| Electric Stimulation | 1 | 2013 | 262 | 0.100 |
Why?
| Pulmonary Gas Exchange | 2 | 2003 | 117 | 0.100 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 316 | 0.100 |
Why?
| Genetic Markers | 1 | 2013 | 322 | 0.100 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 245 | 0.100 |
Why?
| Macrophages | 2 | 2017 | 1266 | 0.100 |
Why?
| Peptide YY | 1 | 2011 | 13 | 0.100 |
Why?
| Models, Animal | 1 | 2013 | 346 | 0.090 |
Why?
| Reference Values | 2 | 2003 | 741 | 0.090 |
Why?
| Islets of Langerhans | 1 | 2017 | 728 | 0.090 |
Why?
| Neutrophils | 1 | 1996 | 1164 | 0.090 |
Why?
| Apoptosis | 4 | 2013 | 2371 | 0.090 |
Why?
| Protein Kinases | 1 | 2012 | 307 | 0.090 |
Why?
| Intestine, Small | 2 | 2022 | 122 | 0.090 |
Why?
| Adult | 10 | 2019 | 30608 | 0.090 |
Why?
| Reproducibility of Results | 1 | 2017 | 2770 | 0.080 |
Why?
| Cell Line, Tumor | 1 | 2016 | 2725 | 0.080 |
Why?
| Synaptic Transmission | 1 | 2011 | 228 | 0.080 |
Why?
| T-Lymphocytes | 1 | 2017 | 1749 | 0.080 |
Why?
| Phenotype | 1 | 2017 | 2817 | 0.080 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2009 | 28 | 0.080 |
Why?
| Receptors, Nicotinic | 1 | 2011 | 275 | 0.080 |
Why?
| HEK293 Cells | 3 | 2017 | 593 | 0.080 |
Why?
| Bone Marrow | 2 | 2021 | 245 | 0.080 |
Why?
| Appetite Regulation | 1 | 2008 | 26 | 0.080 |
Why?
| Sympathomimetics | 2 | 2005 | 25 | 0.080 |
Why?
| Disease Susceptibility | 1 | 2010 | 316 | 0.080 |
Why?
| Glycolysis | 2 | 2021 | 227 | 0.080 |
Why?
| RNA, Messenger | 2 | 2014 | 2559 | 0.080 |
Why?
| Receptors, Mineralocorticoid | 1 | 2008 | 7 | 0.080 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 140 | 0.070 |
Why?
| Infusions, Parenteral | 1 | 2007 | 36 | 0.070 |
Why?
| Rodentia | 2 | 2019 | 44 | 0.070 |
Why?
| Smoking Cessation | 1 | 2011 | 374 | 0.070 |
Why?
| Fatty Acids, Nonesterified | 2 | 2008 | 151 | 0.070 |
Why?
| Human Growth Hormone | 2 | 2005 | 38 | 0.070 |
Why?
| Treatment Outcome | 2 | 2016 | 9105 | 0.070 |
Why?
| Infusions, Intraventricular | 2 | 2017 | 4 | 0.060 |
Why?
| Injections, Intravenous | 1 | 2004 | 201 | 0.060 |
Why?
| Rats, Wistar | 2 | 2016 | 368 | 0.060 |
Why?
| Consciousness | 1 | 2003 | 20 | 0.060 |
Why?
| Gluconeogenesis | 1 | 2003 | 62 | 0.050 |
Why?
| Blood Pressure | 3 | 2005 | 1537 | 0.050 |
Why?
| Glutamate-Ammonia Ligase | 1 | 2022 | 5 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2004 | 372 | 0.050 |
Why?
| Pancreatitis-Associated Proteins | 1 | 2022 | 5 | 0.050 |
Why?
| Heart Rate | 2 | 2005 | 705 | 0.050 |
Why?
| Glutamine | 1 | 2022 | 91 | 0.050 |
Why?
| Differential Threshold | 1 | 2002 | 5 | 0.050 |
Why?
| gamma-Aminobutyric Acid | 1 | 2022 | 144 | 0.050 |
Why?
| Amino Acid Transport System y+L | 1 | 2020 | 4 | 0.050 |
Why?
| Absorption, Physiological | 1 | 2020 | 4 | 0.050 |
Why?
| Epididymis | 1 | 2020 | 9 | 0.050 |
Why?
| Protein Phosphatase 2C | 1 | 2020 | 14 | 0.050 |
Why?
| Blood Circulation | 1 | 2020 | 34 | 0.050 |
Why?
| Respiratory System | 1 | 2002 | 138 | 0.050 |
Why?
| Kinetics | 1 | 2004 | 1555 | 0.040 |
Why?
| Ceruletide | 2 | 1997 | 5 | 0.040 |
Why?
| Exercise Test | 1 | 2003 | 545 | 0.040 |
Why?
| Oxygen Consumption | 1 | 2003 | 588 | 0.040 |
Why?
| CLOCK Proteins | 1 | 2019 | 8 | 0.040 |
Why?
| Analysis of Variance | 1 | 2003 | 1227 | 0.040 |
Why?
| Prolactin | 1 | 2019 | 95 | 0.040 |
Why?
| Diet, Reducing | 1 | 2019 | 78 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2008 | 1134 | 0.040 |
Why?
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2018 | 3 | 0.040 |
Why?
| Vesicular Glutamate Transport Protein 2 | 1 | 2018 | 10 | 0.040 |
Why?
| Altitude Sickness | 1 | 2000 | 172 | 0.040 |
Why?
| Colon | 1 | 2020 | 233 | 0.040 |
Why?
| GABAergic Neurons | 1 | 2018 | 21 | 0.040 |
Why?
| Epigenesis, Genetic | 1 | 2022 | 523 | 0.040 |
Why?
| Bone Density | 1 | 2021 | 430 | 0.040 |
Why?
| Acute Disease | 2 | 2000 | 915 | 0.040 |
Why?
| Positron-Emission Tomography | 1 | 2019 | 265 | 0.040 |
Why?
| Leukocytes | 1 | 2019 | 277 | 0.040 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.040 |
Why?
| Adenylate Kinase | 1 | 2017 | 27 | 0.040 |
Why?
| Genes, Reporter | 1 | 2018 | 257 | 0.040 |
Why?
| Cricetulus | 1 | 2017 | 97 | 0.040 |
Why?
| CHO Cells | 1 | 2017 | 138 | 0.040 |
Why?
| Random Allocation | 1 | 2018 | 335 | 0.040 |
Why?
| CD4-CD8 Ratio | 1 | 2017 | 19 | 0.040 |
Why?
| Phosphorylation | 2 | 2018 | 1572 | 0.040 |
Why?
| Pro-Opiomelanocortin | 1 | 2016 | 17 | 0.040 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 1997 | 139 | 0.040 |
Why?
| Ginkgolides | 1 | 1996 | 4 | 0.030 |
Why?
| Amylases | 1 | 1996 | 14 | 0.030 |
Why?
| Dietary Supplements | 1 | 2020 | 458 | 0.030 |
Why?
| Antigens, CD19 | 1 | 1997 | 91 | 0.030 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1997 | 107 | 0.030 |
Why?
| Case-Control Studies | 1 | 2003 | 3008 | 0.030 |
Why?
| Metformin | 1 | 2020 | 278 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2018 | 373 | 0.030 |
Why?
| Tyrosine | 1 | 1997 | 216 | 0.030 |
Why?
| Lipase | 1 | 1996 | 57 | 0.030 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 400 | 0.030 |
Why?
| Lactones | 1 | 1996 | 54 | 0.030 |
Why?
| Adipokines | 1 | 2016 | 42 | 0.030 |
Why?
| Catecholamines | 1 | 2016 | 95 | 0.030 |
Why?
| Altitude | 1 | 2000 | 433 | 0.030 |
Why?
| Mutation | 2 | 2019 | 3354 | 0.030 |
Why?
| Immunoglobulin M | 1 | 1997 | 251 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 299 | 0.030 |
Why?
| Nerve Net | 1 | 2018 | 225 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2018 | 617 | 0.030 |
Why?
| Pancreatic Ducts | 1 | 1996 | 69 | 0.030 |
Why?
| Receptors, Gastrointestinal Hormone | 1 | 2014 | 5 | 0.030 |
Why?
| Peptide Hormones | 1 | 2014 | 8 | 0.030 |
Why?
| Insulin-Like Growth Factor I | 1 | 2017 | 286 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2017 | 359 | 0.030 |
Why?
| Nerve Tissue Proteins | 1 | 2018 | 529 | 0.030 |
Why?
| Paracrine Communication | 1 | 2014 | 56 | 0.030 |
Why?
| Transcription Factors | 1 | 2022 | 1530 | 0.030 |
Why?
| Cecum | 1 | 2014 | 32 | 0.030 |
Why?
| Peripheral Nerves | 1 | 2014 | 65 | 0.030 |
Why?
| Ribosomal Protein S6 Kinases | 1 | 2013 | 21 | 0.030 |
Why?
| Dendritic Cells | 1 | 2017 | 436 | 0.030 |
Why?
| Glucose Transporter Type 4 | 1 | 2013 | 36 | 0.030 |
Why?
| Tamoxifen | 1 | 2014 | 192 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2017 | 1856 | 0.030 |
Why?
| Dopamine beta-Hydroxylase | 1 | 2012 | 12 | 0.030 |
Why?
| Food, Formulated | 1 | 2012 | 14 | 0.030 |
Why?
| Soybean Oil | 1 | 2012 | 12 | 0.030 |
Why?
| Cues | 1 | 2015 | 301 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2019 | 2382 | 0.030 |
Why?
| Organ Size | 1 | 2013 | 435 | 0.030 |
Why?
| Emulsions | 1 | 2012 | 42 | 0.030 |
Why?
| Caloric Restriction | 1 | 2013 | 90 | 0.030 |
Why?
| Sucrose | 1 | 2012 | 91 | 0.030 |
Why?
| Intubation, Gastrointestinal | 1 | 2012 | 53 | 0.030 |
Why?
| B-Lymphocytes | 1 | 1997 | 772 | 0.030 |
Why?
| Carnitine | 1 | 2012 | 62 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2012 | 164 | 0.020 |
Why?
| Homozygote | 1 | 2012 | 188 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2012 | 168 | 0.020 |
Why?
| Phospholipids | 1 | 2012 | 197 | 0.020 |
Why?
| Choice Behavior | 1 | 2012 | 155 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 350 | 0.020 |
Why?
| Chronic Disease | 1 | 2016 | 1593 | 0.020 |
Why?
| Hyperlipidemias | 1 | 2011 | 122 | 0.020 |
Why?
| Agouti-Related Protein | 1 | 2010 | 2 | 0.020 |
Why?
| Neuropeptide Y | 1 | 2010 | 13 | 0.020 |
Why?
| Genetic Association Studies | 1 | 2012 | 345 | 0.020 |
Why?
| United States | 1 | 2006 | 12211 | 0.020 |
Why?
| Reward | 1 | 2012 | 211 | 0.020 |
Why?
| Taste | 1 | 2012 | 209 | 0.020 |
Why?
| Cannabinoid Receptor Modulators | 1 | 2009 | 6 | 0.020 |
Why?
| Water | 1 | 2012 | 399 | 0.020 |
Why?
| Behavior, Animal | 1 | 2012 | 462 | 0.020 |
Why?
| Chemokine CCL3 | 1 | 2008 | 15 | 0.020 |
Why?
| Receptors, CCR2 | 1 | 2008 | 28 | 0.020 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 54 | 0.020 |
Why?
| Mesentery | 1 | 2008 | 53 | 0.020 |
Why?
| Chemokine CCL2 | 1 | 2008 | 105 | 0.020 |
Why?
| Fludrocortisone | 1 | 2008 | 3 | 0.020 |
Why?
| Cell Count | 1 | 2008 | 305 | 0.020 |
Why?
| Piperidines | 1 | 2009 | 162 | 0.020 |
Why?
| Genotype | 1 | 2012 | 1775 | 0.020 |
Why?
| Genetic Variation | 1 | 2012 | 876 | 0.020 |
Why?
| Mitochondria | 1 | 2012 | 751 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2008 | 370 | 0.020 |
Why?
| Antigens, CD | 1 | 2008 | 443 | 0.020 |
Why?
| Pyrazoles | 1 | 2009 | 364 | 0.020 |
Why?
| Pancreatic Polypeptide | 1 | 2005 | 4 | 0.020 |
Why?
| Calorimetry, Indirect | 1 | 2005 | 69 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2005 | 387 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2005 | 718 | 0.010 |
Why?
| Peptide Fragments | 1 | 2005 | 668 | 0.010 |
Why?
| Biopsy | 1 | 2005 | 1045 | 0.010 |
Why?
| Adolescent | 1 | 2019 | 17829 | 0.010 |
Why?
| Atmospheric Pressure | 1 | 2000 | 18 | 0.010 |
Why?
| Drinking | 1 | 2000 | 33 | 0.010 |
Why?
| Urination | 1 | 2000 | 41 | 0.010 |
Why?
| Kidney Function Tests | 1 | 2000 | 140 | 0.010 |
Why?
| Models, Biological | 1 | 2005 | 1630 | 0.010 |
Why?
| Precipitin Tests | 1 | 1997 | 88 | 0.010 |
Why?
| Neutralization Tests | 1 | 1997 | 63 | 0.010 |
Why?
| Cell Compartmentation | 1 | 1997 | 52 | 0.010 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 41 | 0.010 |
Why?
| Biological Assay | 1 | 1997 | 113 | 0.010 |
Why?
| Cell Separation | 1 | 1997 | 292 | 0.010 |
Why?
| Opossums | 1 | 1996 | 10 | 0.010 |
Why?
| Ligation | 1 | 1996 | 75 | 0.010 |
Why?
| Rabbits | 1 | 1997 | 748 | 0.010 |
Why?
| Microscopy, Electron | 1 | 1996 | 410 | 0.010 |
Why?
| Antibodies | 1 | 1997 | 372 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 797 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 1997 | 330 | 0.010 |
Why?
| Necrosis | 1 | 1996 | 210 | 0.010 |
Why?
| Cell Death | 1 | 1996 | 325 | 0.010 |
Why?
| NF-kappa B | 1 | 1997 | 637 | 0.010 |
Why?
| DNA Damage | 1 | 1996 | 357 | 0.010 |
Why?
| Lymphocyte Activation | 1 | 1997 | 1045 | 0.010 |
Why?
| Kidney | 1 | 2000 | 1184 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2000 | 2542 | 0.010 |
Why?
| Protein Binding | 1 | 1997 | 1897 | 0.010 |
Why?
| Cells, Cultured | 1 | 1997 | 3897 | 0.010 |
Why?
| DNA | 1 | 1996 | 1351 | 0.010 |
Why?
|
|
Sandoval's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|